Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Am J Prev Med. 2016 Apr 1;51(4):e107–e115. doi: 10.1016/j.amepre.2016.02.025

Table 3.

Among Those Completing FIT/gFOBT, Odds of a Positive FIT/gFOBT by Race/Ethnicity: PROSPR Cohort 2010–2012

Positive FIT/gFOBT % AORa 95% CI AORb 95% CI
Overall N=1,014,156
Non-Hispanic white 6.0 1.00 (ref) 1.00 (ref)
Non-Hispanic black 6.3 1.10 1.07–1.14 1.00 0.96–1.03
Hispanic 5.6 0.95 0.93–0.97 0.90 0.88–0.92
Asian/Pacific Islander 5.6 0.97 0.94–0.99 0.97 0.95–1.00
American Indian/Alaska Native 7.4 1.29 1.15–1.45 1.21 1.08–1.36
Multiple/other 6.8 1.22 1.15–1.29 1.14 1.07–1.21
a

Adjusted for age, sex, length of prior enrollment, and study site

b

Adjusted for age, sex, study site, length of prior enrollment, ZIP code median income type of residence, insurance type, and Charlson co-morbidity score

FIT, fecal immunochemical test; FOBT, fecal occult blood test; PROSPR, Population-based Research Optimizing Screening through Personalized Regimens